ArticleFrontiers in immunology2026
Aquaporin-5-specific heavy chain VDJ knock-in (A5H) mice reveal molecular mimicry-driven initiation and diversification of autoreactive B-cell responses.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Molecular mimicry, where microbial antigens resemble self-antigens, is implicated in triggering autoimmune responses, yet the early B-cell events leading to autoantibody production remain unclear. Here, we generated A5H mice, a knock-in model in which a heavy chain binding to the aquaporin-5 (AQP5) "E" epitope (AQP5E) preferentially generates B cells recognizing a microbial mimic peptide (PmE-L). A5H mice exhibited normal B-cell development with a phenotypic reduction in the anergy-associated B-cell compartment and an expanded pool of mimic-reactive B cells. At steady state, A5H mice produced anti-PmE-L antibodies, whereas anti-AQP5E autoantibodies were not detectable by ELISA. Upon immunization with PmE-L, mimic-reactive B cells were recruited into germinal center responses, leading to robust production of anti-AQP5E autoantibodies that cross-reacted with homologous AQPs (AQP4 and AQP1). Furthermore, A5H mice generated anti-AQP5E autoantibodies upon immunization with streptavidin-complexed PmE-L, indicating that A5H-derived mimic-reactive B cells can overcome competition with the immunodominant carrier antigen streptavidin. However, evidence of intramolecular epitope spreading to native AQP5 was not observed. Consistently, tissue deposition of autoantibodies and salivary gland pathology remained minimal. Notably, autoantibody responses were stronger in heterozygous (+/A5H) than homozygous (A5H/A5H) mice, indicating that allelic inclusion enhances autoreactive B-cell activation. These findings establish A5H mice as a valuable model to dissect how molecular mimicry initiates and diversifies autoreactive B-cell responses, advancing understanding of autoimmune disease initiation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.